Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01470131
Title A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors AB Science
Indications

multiple myeloma

Therapies

Masitinib

Bortezomib + Dexamethasone

Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Medical and Surgical Specialists Galesburg Illinois 61401 United States Details
Center for Cancer and Blood Disorders Bethesda Maryland 20817 United States Details
Carolinas Medical Center Charlotte North Carolina 28203 United States Details
Southeastern Medical Oncology Center Goldsboro North Carolina 27534 United States Details
Froedtert & Medical College of Wisconsin-CLCC Milwaukee Wisconsin 53226 United States Details
CHU Estaing Clermont Ferrand France Details
Centre Hospitalier Sud Francilien Corbeil-Essonnes France Details
CH Le Mans Le Mans France Details
Hôpital Universitaire Dupuytren Limoges France Details
Hôpital Ambroise Paré Marseille France Details
Hôpital de l'Hôtel Dieu Nantes France Details
Hôpital Saint Louis Paris France Details
Centre Hospitalier Saint Jean Perpignan France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field